Glyphic Biotechnologies website screenshot

Glyphic Biotechnologies

Glyphic Biotechnologies is a Berkeley, California proteomics company founded in 2021 that is developing ProSE (Protein Sequencing by Expansion) — a de novo, high-throughput, single-molecule protein sequencing technology designed to discriminate all 20 amino acids and their post-translational modifications. The company aims to make massively parallel proteome sequencing broadly accessible for drug discovery and biological research, and is backed by Wing Venture Capital. Glyphic currently publishes no public developer API, SDKs, or documentation surface; this profile captures its identity and domain-security posture in the API Evangelist network.

Glyphic Biotechnologies is profiled on the APIs.io network. Tagged areas include Company, Proteomics, Protein Sequencing, Biotechnology, and Life Sciences.

Glyphic Biotechnologies’ developer surface includes support and 8 more developer resources.

14.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyProteomicsProtein SequencingBiotechnologyLife SciencesSingle-Molecule SequencingDrug Discovery

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 14.6/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.9 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/glyphic-biotechnologies: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Glyphic Biotechnologies Domain Security

TLSv1.3 · HSTS · DNSSEC · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 2

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 3

The organization behind the API

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: glyphic-biotechnologies
name: Glyphic Biotechnologies
description: Glyphic Biotechnologies is a Berkeley, California proteomics company founded in 2021 that is developing ProSE
  (Protein Sequencing by Expansion) — a de novo, high-throughput, single-molecule protein sequencing technology designed to
  discriminate all 20 amino acids and their post-translational modifications. The company aims to make massively parallel
  proteome sequencing broadly accessible for drug discovery and biological research, and is backed by Wing Venture Capital.
  Glyphic currently publishes no public developer API, SDKs, or documentation surface; this profile captures its identity
  and domain-security posture in the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/glyphic-biotechnologies/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- wing-venture-capital
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
image: https://public-website-tfib.onrender.com/uploads/social_a5c45b485d.jpg
tags:
- Company
- Proteomics
- Protein Sequencing
- Biotechnology
- Life Sciences
- Single-Molecule Sequencing
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/glyphic-biotechnologies-domain-security.yml
- type: Website
  url: https://glyphic.bio/
- type: PrivacyPolicy
  url: https://glyphic.bio/privacy-policy
- type: TermsOfService
  url: https://glyphic.bio/terms-of-use
- type: Support
  url: https://glyphic.bio/#contact-us
- type: HelpCenter
  url: https://glyphic.bio/faqs
- type: Careers
  url: https://job-boards.greenhouse.io/glyphicbiotechnologies
- type: LinkedIn
  url: https://www.linkedin.com/company/glyphicbio/
- type: X
  url: https://x.com/GlyphicBio
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence